Publications by authors named "M Jaremko"

The primary method used to pharmacologically arrest cancer development and its metastasis is to disrupt the cell division process. There are a few approaches that may be used to meet this objective, mainly through inhibiting DNA replication or mitosis. Despite intensive studies on new chemotherapeutics, the biggest problem remains the side effects associated with the inhibition of cell division in non-tumoural host cells.

View Article and Find Full Text PDF

Multi-drug-resistant (MDR) pathogens represent a critical global health threat, necessitating the development of novel antimicrobial agents with broad-spectrum activity and minimal toxicity. This study investigates the antimicrobial and anti-biofilm properties of 4-Allyl-2-methoxyphenol (eugenol, EU) and (E)-3-Phenylprop-2-enal (cinnamaldehyde, CN) against 19 clinically significant pathogens through a combination of in-vitro assays and in-silico analyses. EU displayed remarkable activity, particularly against Aspergillus niger (20.

View Article and Find Full Text PDF

Herbal medicine, particularly in developing regions, remains highly popular due to its cost-effectiveness, accessibility, and minimal risk of adverse effects. L., commonly known as turmeric, exemplifies such herbal remedies with its extensive history of culinary and medicinal applications across Asia for thousands of years.

View Article and Find Full Text PDF

This study aimed to optimize mesalamine (MES)-nanoparticles (NPs) using Box Behnken Design and investigate itsantioxidant potential in colon drug targeting. The formulation was prepared using oil/water (O/W) emulsion solvent evaporation technique for time dependent colonic delivery. The optimal formulation with the following parameters composition was selected: polymer concentration (% w/w) (A) = 0.

View Article and Find Full Text PDF
Article Synopsis
  • - The paper offers an in-depth analysis of biomarkers associated with head and neck cancer (HNC), discussing key proteins and genes that play significant roles in the disease's development and progression.
  • - Important genes linked to HNC progression include AURKA, HMGA2, and others, while specific microRNAs (OncomiRs) are shown to promote tumor growth, with some, like hsa-miR-155-3p, indicating potential for prognosis.
  • - Future research should focus on applying precision medicine and advanced therapies, including AI, to enhance personalized treatment approaches for better patient outcomes in HNC care.
View Article and Find Full Text PDF